Abstract. microRNAs (miRNAs) play essential roles in several physiological and pathological processes, including tumor metastasis. Metastasis is associated with poor prognosis in renal carcinoma patients and almost 20-30% of patients present with distant metastasis at the time of diagnosis. The aim of the present study was to investigate the possible roles of miR-200c in regulating metastasis and to identify its target genes in renal cell carcinoma (RCC). Among the miRNAs downregulated in our tissue specimen microarray, miR-200c was downregulated significantly. Functional assays demonstrated that restoration of miR-200c significantly inhibited the migration and invasion of SN12-PM6 and 786-0 cells in vitro. Genome-wide gene expression analysis and TargetScan database studies showed that ZEB1, which has been shown to promote tumor invasion and migration through E-cadherin gene silencing, is a promising candidate target gene of miR-200c. Overexpression of miR-200c in SN12-PM6 and 786-0 cells was concurrent with downregulation of ZEB1 and upregulation of E-cadherin mRNA and protein. In addition, miR-200c affected the protein expression of p-Akt and Akt. Thus, our study demonstrated that miR-200c decreases the metastatic ability of renal carcinoma cells by upregulating E-cadherin through ZEB1 and that modulating the expression of miR-200c could influence Akt protein levels. We therefore concluded that there is an Akt-miR-200c-E-cadherin axis in the epithelial-to-mesenchymal transition process in RCC.
Introduction microRNAs (miRNAs) constitute a class of 20-22-nt noncoding single-strand RNA that are initially synthesized by RNA polymerase Ⅱ as long primary transcripts, which are subsequently capped and polyadenylated. These precursors of miRNAs, pri-miRNAs, are cleaved by Drosha into pre-miRNAs and transported out of the nucleus by exportin-5. Pre-miRNAs are further processed by Dicer in the cytoplasm to yield mature miRNAs. Through base pairing to the 3' untranslated region (3'UTR) of mRNA, miRNAs negatively regulate gene expression post-transcriptionally to induce suppression of translation or degradation of multiple mRNAs. They are thus crucial players that participate in numerous key cellular processes such as cell growth, differentiation and death (1) (2) (3) . In malignancy, functional characterization has revealed a role for miRNAs as oncogenes or tumor-suppressor genes (4) . The contribution of miRNAs to the malignant progression of human tumors was recently investigated. Malignant tumor progression shares several characteristics with the process of epithelialto-mesenchymal transition (EMT), which facilitates tissue remodeling during embryonic development and is considered an essential early step in tumor metastasis. In EMT, epithelial tumor cells are stimulated by extracellular cytokines to lose their epithelial polarity and gain mesenchymal phenotypes with increased migratory and invasive capabilities (5, 6) . One of the molecular hallmarks driving this transition is the functional loss of E-cadherin, which is a cell adhesion protein and a major constituent of adherens junctions, and is thought to be a suppressor of migration/invasion during carcinoma progression (7, 8) . Recent studies have indicated that the expression of the miRNA-200 family (miR-200a, miR-200b, miR-200c, miR-141 and miR-429) is markedly downregulated in cells that have undergone EMT. By serving as a powerful regulator of the EMT, miR-200c can maintain the epithelial phenotype of tissues by suppressing expression of the E-cadherin transcription factor ZEB1 in some types of cancer (9) (10) (11) (12) (13) .
Renal cell carcinoma (RCC) is the third most common urological cancer after prostate and bladder cancer, and it accounts for approximately 3% of adult malignancies and 90-95% of neoplasms arising from the kidney (14, 15) . Previous studies have shown that almost 20-30% of patients have distant metastasis when diagnosed and that metastasis is associated with poor prognosis. The mechanisms underlying metastasis are multifaceted and intricate. It is therefore important to explore metastatic mechanisms in RCC as these may provide new targets for treating metastasis. In this study, we investigated the possible metastatic mechanisms of action of miR-200c in 2 RCC cell lines: the 786-0 cancer cell line, derived from primary human RCC in a 58-year-old male patient, and the SN12-PM6 cancer cell line, obtained from lung metastases produced in nude mice (16, 17) . miRNA microarray and analysis. A miRNA microarray platform was used to determine the expression profiles of miRNA in 5 paired RCCs and normal renal tissues. The array used was the commercially available G4471A Human miRNA Microarray (Agilent Technologies, Santa Clara, CA, USA), which consists of 961 probes for 851 human miRNAs, and is based on Sanger miRBase release 12.0. The arrays were washed and scanned using a laser confocal scanner (G2565BA; Agilent Technologies) according to the manufacturer's instructions. The fluorescence intensity was calculated using the Feature Extraction software (Agilent Technologies). Differentially expressed miRNAs were identified using a filter based on a 2-fold change in expression, combined with ANOVA analysis (P<0.01).
Materials and methods

Clinical
Lentivirus production and transduction. We used the lentiviral vector pGCSIL-GFP (GeneChem Co., Ltd., Shanghai, China) to construct the hsa-miR-200c lentiviral expression vector pGCSIL-GFP-hsa-miR-200c as well as the lentiviral vector pGCSIL-GFP-negative as a negative control. For 6-well transduction in SN12-PM6 and 786-0 cells, cells were plated at a density of 150,000/well in a 6-well dish. When the cells were 50% confluent, they were transduced with recombinant lentivirus vectors at a multiplicity of infection (MOI) of 30 and 10, respectively, and supplemented with 5 µg/ml polybrene from GeneChem Co., Ltd. The cells were then collected for western blot analysis, quantitative RT-PCR (qRT-PCR), and migration and invasion assays. The SN12-PM6 cell line stably expressing miR-200c was termed SN12-PM6 miR-200c; the negative control cell line was termed SN12-PM6 miR-Ctr. We also generated 786-0 miR-200c and 786-0 miR-Ctr cells.
Cell culture and transfection. All cell lines were maintained in DMEM medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal bovine serum (Gibco-BRL, Grand Island, NY, USA), 100 U/ml penicillin, and 100 µg/ml streptomycin at 37˚C in a humidified atmosphere containing 5% CO 2 . Lipofectamine™ 2000 (Invitrogen) was used to transfect SN12-PM6 miR-200c and 786-0 miR-200c with the antagomiR-200c (RiboBio Co., Ltd., Guangzhou, China) according to the manufacturer's instructions.
Transwell migration and invasion assays. For transwell migration assays, 20,000 cells were plated in the top chamber onto a non-coated membrane (24-well insert; pore size, 8 µm; Corning-Costar, Corning, NY, USA). For invasion assays, 20,000 cells were plated in the top chamber onto a Matrigelcoated membrane. Each well was freshly coated with 60 µg of Matrigel (BD Biosciences, Franklin Lakes, NJ, USA) prior to the invasion assay. In both assays, cells were plated in medium without serum or growth factors, and medium supplemented with serum was used as a chemoattractant in the lower chamber. The cells were incubated for 24 h in the migration and the invasion assay, and cells that did not migrate or invade through the pores were removed with a cotton swab. Cells on the lower surface of the membrane were fixed with methanol and stained with crystal violet. The cells migrating or invading through the membrane were counted with a Nikon Eclipse TE2000-S (Nikon, Japan) at x100 magnification in 4 random fields/well.
Quantitative RT-PCR analysis. Total RNA was extracted using TRIzol (Invitrogen), and 1-µg RNA samples were reverse transcribed to cDNA by using reverse transcriptase M-MLV (Invitrogen). qRT-PCR was performed using the SYBR-Green PCR master mix (Invitrogen) on a Roche LightCycler 480 System (Roche Diagnostics, Germany). For analysis of miRNA expression by qRT-PCR, reverse transcription and PCR were conducted using a Bulge-Loop™ miRNA qPCR Primer Set for hsa-miR-200c and U6 snRNA (RiboBio Co., Ltd.) according to the manufacturer's instructions. Other primers used in qRT-PCR are described in Table Ι . GAPDH and U6 snRNA were used as endogenous controls.
Western blot analysis. Whole-cell lysates were prepared using RIPA buffer (Beyotime, Shanghai, China) containing a cocktail of protease inhibitors and phosphatase inhibitors (Roche Applied Science, Indianapolis, IN, USA). Equal amounts of protein sample (40-60 µg) were separated by 10% SDS-PAGE and transferred to a PVDF membrane (Millipore, Bedford, MA, USA) using the Invitrogen semidry transfer system and then incubated with the specific primary antibody overnight at 4˚C. The membranes were then washed and subsequently incubated with a secondary antibody conjugated to horseradish peroxidase (HRP). The protein detected was then visualized using enhanced chemiluminescence. The following antibodies were used for western blotting: anti-β-actin (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), anti-E-cadherin and anti-ZEB1 (both from Bioworld, Minneapolis, MN, USA), anti-Akt and anti-p-Akt (both from Cell Signaling Technology, Beverly, MA, USA). The blotted proteins were detected and quantified using ChemiDoc-XRS+ (Bio-Rad, USA).
Statistical analysis.
Data from different experiments are presented in terms of mean ± standard deviation (SD) values. Differences among different groups with respect to the number of cancer cells in the invasion and migration assays were compared using the paired-samples t-test. P<0.05 was considered to indicate a statistically significant difference.
Results
Downregulated miRNAs in RCC and normal renal tissues.
A comprehensive miRNA expression profile was obtained for the 5 paired RCC and normal renal tissues. Fig. 1A shows miRNAs that were downregulated in tumors relative to normal tissues: 12 miRNAs were downregulated >4-fold in tumor tissues, as listed in Table II . miR-200c was one of the most strongly downregulated miRNAs in tumor tissues, which was expected, as it had already been shown to inhibit metastasis in some types of tumors. We further examined the expression of miR-200c in 20 more pairs of RCC and normal human specimens to validate the microarray data and found that the data for 19 of 20 pairs were consistent with the microarray data in that miR-200c expression was significantly lower in RCCs than in normal kidney tissues (Fig. 1B) . Therefore, miR-200c was selected for further study. (Fig. 2B) .
miR-200c inhibits migration and invasion in SN12-PM6 and 786-0 cancer cells.
To validate the involvement of miR-200c dysregulation in migration and invasion, functional analysis was performed to test the effects of miR-200c. In the migration test, the mean number of SN12-PM6 cells expressing miR-200c per field was 30, which was significantly different from that for the control group. The mean number of 786-0 cells expressing miR-200c per field was 21, which was also significantly different from the control group. In the invasion test, the mean number of SN12-PM6 and 786-0 cells expressing miR-200c per field was 45 and 20, respectively, which was significantly different from the number for the control group (Fig. 3A) . To further explore the role of miR-200c and to determine whether inhibition of miR-200c could reverse the inhibition of cellular migration and invasion produced by overexpression, loss-of-function analyses (Fig. 4A and B) . Next, we analyzed whether miR-200c, ZEB1 and E-cadherin were correlated in RCC cells and human cancer tissues. We measured the expression of miR-200c, ZEB1, and E-cadherin in SN12-PM6 cells, 786-0 cells, and 20 pairs of human RCC tissues by qRT-PCR. The expression of miR-200c was inversely correlated with that of ZEB1 but positively correlated with that of E-cadherin (Fig. 4C) .
miR-200c is involved in the regulation of p-Akt and Akt protein expression.
Akt is involved in a number of basic cellular processes, including EMT. Akt strongly represses transcription of the E-cadherin gene and internalization/sequestration of E-cadherin in perinuclear organelles to induce EMT (20, 21) . We found that overexpression of miR-200c in SN12-PM6 and 786-0 cells was able to inhibit the protein expression of p-Akt and Akt and that blockade of miR-200c could reverse this result (Fig. 5A) . 
Discussion
Previous studies have linked the miR-200 family with the epithelial phenotype and the ZEB family. miR-200c is a member of the miR-200 family; this family has been associated with metastasis in several types of tumors, particularly through negative correlation with ZEB1, which inhibits EMT (9, 22, 23) . In breast cancer, melanoma, and pancreatic cancer, miR-200c suppresses tumor migration and invasion (24) (25) (26) . Nakada et al (27) We then identified miR-200c as a suppressor of EMT through direct targeting of ZEB1, which is a well-known transcriptional repressor of E-cadherin. miRNA target prediction programs and previous studies have indicated that ZEB1 has 2 target sites for miR-200c (Fig. 4D) , as confirmed by luciferase reporter assays (8, 19, 30) . ZEB1 is a crucial inducer of EMT, which has been shown to promote tumor invasion and migration through E-cadherin gene silencing (9, 12) . In our present study, we analyzed whether miR-200c played a role in the regulation of metastasis in these 2 renal carcinoma cells by targeting ZEB1. Using quantitative RT-PCR (qRT-PCR), we observed that stable overexpression of miR-200c by an hsa-miR-200c lentivirus in SN12-PM6 and 786-0 cells led to decreased expression of ZEB1 and increased expression of E-cadherin, whereas blockade of miR-200c in SN12-PM6 miR-200c and 786-0 miR-200c cells led to restoration of ZEB1 expression and decreased E-cadherin expression. These results were observed at the protein level as well as the mRNA level. We also found that ZEB1 expression was inversely correlated with miR-200c expression in RCC cells and human RCC specimens. These data demonstrate that increased expression of miR-200c results in negative regulation of its gene target ZEB1, which regulates E-cadherin expression to trigger EMT in RCC cells.
Collectively, these findings suggest a potential tumor suppressor role for miR-200c, which is downregulated in human RCC, thereby leading to EMT and tumor cell invasion and metastasis. Loss of miR-200c is associated with an aggressive cancer cell phenotype. According to previous research and our data, Akt is frequently activated in human epithelial cancer and the PI3K/Akt pathway plays a pivotal role in RCC pathogenesis (31, 32) . Additionally, Akt has been found to regulate E-cadherin mRNA and protein and to induce EMT (20) , and miR-200c regulates the expression of E-cadherin by targeting ZEB1 in some cancer cell lines, including RCC cell lines (12). Finally, miR-200c is downregulated in human RCC specimens and regulates the protein level of Akt in RCC cell lines. We therefore consider that RCC metastasis may be under the control of the Akt-miR-200c-E-cadherin axis. A summary diagram that outlines this hypothesis is shown in Fig. 5B . Our future work will focus on the identification and functional characterization of additional direct miR-200c downstream targets and metastasis promoter proteins, as well as the specific mechanism underlying the regulation of miR-200c by Akt. This will improve our understanding of the events contributing to EMT and metastasis, leading to the development of novel therapeutic strategies for RCC.
